<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Asthma • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Asthma • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/Asthma/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/Asthma/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="asthma" tabindex="-1">Asthma</h1>
<ul>
<li>related: <a href="/wiki/notes/Pulmonology/">Pulmonology</a></li>
</ul>
<hr>
<p>Asthma</p>
<!-- asthma severity and therapy -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/image-20200203203155464.png" alt=""></p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/20220813145028.png" alt=""></p>
<p>This patient has <strong>intermittent asthma</strong> symptoms (less than daily, no waking, normal postbronchodilator FEV1).  Guidelines recommend treatment with an inhaled corticosteroid (ICS) (eg, budesonide) plus formoterol as needed.  This strategy addresses <strong>leukocyte-induced bronchoconstriction</strong> as the central pathophysiology of asthma:</p>
<ul>
<li>
<p>ICSs target leukocytes and should be included at <strong>every step</strong> of asthma, even for patients with intermittent symptoms.</p>
</li>
<li>
<p>Formoterol targets bronchoconstriction and is the preferred long-acting beta agonist (LABA) because it has <strong>fast-onset</strong> kinetics (&lt;5 min) and is therefore effective for acute relief.</p>
</li>
</ul>
<p>Short-acting beta agonists (SABAs) (eg, albuterol) are an alternative to formoterol in patients with very infrequent intermittent symptoms, but ICSs should be taken when a SABA is used.  SABA monotherapy increases the risk for future exacerbation, probably because the underlying airway inflammation is not addressed.  Frequent SABA use also down-regulates airway beta-2 receptors, which dampens bronchodilator responsiveness over time.</p>
<p>Long-acting antimuscarinic agents (LAMA) (eg, tiotropium) are indicated for step-up therapy in patients with uncontrolled asthma despite scheduled high-dose ICS-formoterol.  LAMA monotherapy is preferred as initial treatment for most patients with COPD; combined LAMA/LABA therapy (eg, umeclidinium-vilanterol) is used for patients who have a higher symptom score and a history of frequent exacerbations (COPD Group D).</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/COPD/" class="peer">COPD</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="copd" tabindex="-1">COPD</h1>
<ul>
<li>related: <a href="/wiki/notes/Pulmonology/">Pulmonology</a>, <a href="/wiki/notes/Asthma/">Asthma</a></li>
<li>tag: #note</li>
</ul>
<hr>
<h2 id="misc" tabindex="-1">MISC</h2>
<ul>
<li><a href="/wiki/notes/COPD%20treatment/">COPD treatment</a></li>
<li><a href="/wiki/notes/COPD%20clinical%20trials/">COPD clinical trials</a></li>
<li><a href="/wiki/notes/pulmonary%20rehabilitation/">pulmonary rehabilitation</a></li>
<li><a href="/wiki/notes/lung%20volume%20reduction%20surgery%20LVRS/">lung volume reduction surgery LVRS</a></li>
</ul>
<h2 id="epidemiology" tabindex="-1">Epidemiology</h2>
<ul>
<li>5% of the U.S. population</li>
</ul>
<h2 id="pathophysiology" tabindex="-1">Pathophysiology</h2>
<ul>
<li>airflow obstruction that's not reversible</li>
<li>inflammatory condition
<ul>
<li>cigarette smoke/irritants activate macrophage/epithelial cells</li>
<li>neutrophil chemotactic factors released</li>
<li>proteases destroys lung parenchyma</li>
<li></li>
</ul>
</li>
</ul>

      </div>
    </div>
  </li>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Pulmonology/" class="peer">Pulmonology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="pulmonology" tabindex="-1">Pulmonology</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<ul>
<li><a href="/wiki/notes/Occupational%20Lung%20Disease/">Occupational Lung Disease</a></li>
<li><a href="/wiki/notes/Diffuse%20Parenchymal%20Lung%20Disease/">Diffuse Parenchymal Lung Disease</a></li>
</ul>
<h2 id="normal" tabindex="-1">Normal</h2>
<ul>
<li><a href="/wiki/notes/pulmonary%20auscultations/">pulmonary auscultations</a></li>
<li><a href="/wiki/notes/bronchoscopy%20guides/">bronchoscopy guides</a></li>
<li><a href="/wiki/notes/segmental%20anatomy/">segmental anatomy</a></li>
</ul>
<h2 id="obstructive-lung-disease" tabindex="-1">Obstructive Lung Disease</h2>
<ul>
<li><a href="/wiki/notes/COPD/">COPD</a></li>
<li><a href="/wiki/notes/Asthma/">Asthma</a></li>
<li><a href="/wiki/notes/acute%20asthma%20exacerbation/">acute asthma exacerbation</a></li>
<li><a href="/wiki/notes/bronchiectasis/">bronchiectasis</a></li>
<li><a href="/wiki/notes/COPD%20patients%20have%20proportional%20pulmonary%20hypertension/">COPD patients have proportional pulmonary hypertension</a></li>
<li><a href="/wiki/notes/pulmonary%20rehabilitation/">pulmonary rehabilitation</a></li>
<li><a href="/wiki/notes/cystic%20fibrosis/">cystic fibrosis</a></li>
<li>[[aspirin exacerbated res</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
